Target intelligence / Profile preview

Protein-glutamine gamma-glutamyltransferase 5 (TGM5)

Target
TGM5
Molecular classification
Enzyme, Transglutaminase family
01

Overview

Protein-glutamine gamma-glutamyltransferase 5 (TGM5) is a calcium-dependent enzyme mainly expressed in the epidermis where it catalyzes the formation of isopeptide bonds (cross-links) between glutamine and lysine residues in structural proteins[1][2][3][4][6][7]. This cross-linking process is essential for the formation and stabilization of the cornified cell envelope, which is critical for skin barrier function and mechanical resilience. Mutations in TGM5 reduce or abolish its enzymatic activity and are causative for acral peeling skin syndrome, a genodermatosis characterized by the painless peeling of the outermost layers of the epidermis, especially on the hands and feet[2][3][4]. TGM5 biology is most relevant in keratinocyte differentiation and skin homeostasis, and its dysfunction has not been directly linked to other major disease categories or targeted by currently approved drugs.

Other names
Transglutaminase 5TG5Transglutaminase XTGXTGase-5TGase XTransglutaminase Vprotein-glutamine gamma-glutamyltransferase 5 isoform 1protein-glutamine gamma-glutamyltransferase 5 isoform 2PSS2TGASE5TGASEX
02

Mechanism of action

Enzyme inhibition or modulation (theoretical for drugs; no approved drugs known)

03

Biological functions

Formation of the cornified cell envelopeProtein cross-linking (between glutamine and lysine residues)Terminal epidermal differentiationRegulation of cell adhesionStabilization of protein assemblies
04

Disease associations

Peeling skin syndrome 2 (acral peeling skin syndrome)Hyperkeratosis (association with ichthyosis and psoriasis)
05

Safety considerations

Loss-of-function can lead to impaired skin barrier and peeling skin disordersNo targeted drugs or therapeutic interventions in current clinical use
06

Biomarkers

TGM5 gene mutations (for acral peeling skin syndrome diagnosis)

Beyond the preview

Go deeper on Protein-glutamine gamma-glutamyltransferase 5 (TGM5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein-glutamine gamma-glutamyltransferase 5 (TGM5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call